Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed.

Related Articles

Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed.

Oncotarget. 2017 Dec 15;8(66):110732

Authors: Zhang N, Kong L, Shi F, Jing W, Wang H, Yang M, Yu J, Zhu H

Abstract
[This corrects the article DOI: 10.18632/oncotarget.20456.].

PMID: 29300397 [PubMed - in process]

http://ift.tt/2m1jk1F